aTyr Pharma develops biologic therapeutics based on Physiocrine biology. The Company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. The Company's key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development.